DAFNA Capital Management’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $119K | Sell |
|
|||||
|
2023
Q3 | $147K | Buy |
|
|||||
|
2023
Q2 | $243K | Sell |
|
|||||
|
2023
Q1 | $506K | Buy |
|
|||||
|
2022
Q4 | $433K | Sell |
|
|||||
|
2022
Q3 | $933K | Sell |
|
|||||
|
2022
Q2 | $2.83M | Buy |
|
|||||
|
2022
Q1 | $1.67M | Buy |
|
|||||
|
2021
Q4 | $1.89M | Hold |
|
|||||
|
2021
Q3 | $2.45M | Buy |
|
|||||
|
2021
Q2 | $1.27M | Buy |
|
|||||
|
2021
Q1 | $1.65M | Sell |
|
|||||
|
2020
Q4 | $2.71M | Buy |
|